AIA AMERICA, INC. v. ELI LILLY & COMPANY , No. 16-2094 (Fed. Cir. 2017)

Annotate this Case

Download PDF

NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ AIA AMERICA, INC., FKA ALZHEIMER'S INSTITUTE OF AMERICA, INC., Plaintiff-Appellant MICHAEL J. MULLAN, RONALD E. SEXTON, Counterclaim Defendants v. ELI LILLY & COMPANY, ELAN PHARMACEUTICALS, INC., Defendants-Appellees ______________________ 2016-2094 ______________________ Appeal from the United States District Court for the Northern District of California in No. 3:10-cv-00482-EDL, Magistrate Judge Elizabeth D. Laporte. ______________________ JUDGMENT ______________________ PETER BUCKLEY, Fox Rothschild, LLP, Philadelphia, PA, argued for plaintiff-appellant. DEBORAH E. FISHMAN, Arnold & Porter Kaye Scholer LLP, Palo Alto, CA, argued for all defendants-appellees. Defendant-appellee Elan Pharmaceuticals, represented by KATIE JEANNINE LEWIS SCOTT. Inc. also LAWRENCE SCOTT BURWELL, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Reston, VA, for defendant-appellee Eli Lilly & Company. Also represented by CHARLES E. LIPSEY; LAURA POLLARD MASUROVSKY, Washington, DC; MANISHA A. DESAI, Eli Lilly and Company, Indianapolis, IN. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (NEWMAN, LOURIE, and HUGHES, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT August 10, 2017 Date /s/ Peter R. Marksteiner Peter R. Marksteiner Clerk of Court

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.